Ipca Mulls Merger Of US Formulations Units
Unichem And Bayshore Could Be Combined Into A Single Entity Under Newly Unveiled Plan
Ipca is considering merging its US generic formulations businesses Bayshore Pharmaceuticals and Unichem Pharmaceuticals USA into a single entity, according to newly-unveiled plans that will be considered by directors in a week’s time.
